A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer

We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy. | A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN